Literature DB >> 1693736

The safety of felodipine.

A R Lorimer1, S D Pringle.   

Abstract

Hypertensive patients, particularly the elderly, may often suffer from other diseases. Therefore, antihypertensive compounds should not negatively affect such disorders. Felodipine is a calcium antagonist that has potentially beneficial effects in angina pectoris and congestive heart failure. Further, it does not adversely affect lung function in asthmatic patients or glucose tolerance in patients with diabetes. Preliminary investigations also indicate that felodipine has no negative influence on plasma lipid levels. Although felodipine seems to be safe in most patients, treatment with felodipine should at present be avoided in pregnant women, since digital anomalies have been observed in rabbit fetuses. The adverse effects seen during treatment with felodipine are usually mild and transient and generally related to the vasodilatory action of the drug, the most common being ankle edema, headache, flushing, dizziness, and palpitations. The only significant drug interactions with felodipine occur with inducers and inhibitors of the cytochrome P-450 system, which is responsible for the metabolism of felodipine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693736     DOI: 10.1097/00005344-199015004-00026

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Preventing injuries in rural Canada.

Authors:  J M Thompson
Journal:  Can Fam Physician       Date:  1995-07       Impact factor: 3.275

2.  Women family physicians and rural medicine. Can the grass be greener in the country.

Authors:  L L Rourke; J Rourke; J B Brown
Journal:  Can Fam Physician       Date:  1996-06       Impact factor: 3.275

3.  Saving Medicare. Is privatization the answer?

Authors:  M Gordon
Journal:  Can Fam Physician       Date:  1996-11       Impact factor: 3.275

4.  Caring for the dying in Canada.

Authors:  E J Latimer
Journal:  Can Fam Physician       Date:  1995-03       Impact factor: 3.275

5.  Equality in health promotion.

Authors:  J K Mills
Journal:  Can Fam Physician       Date:  1996-03       Impact factor: 3.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.